期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

体外树突状细胞疫苗策略抗肿瘤免疫治疗研究进展 被引量：2

Study progress about ex vivo dendritic cells therapy for antitumor immunotherapy
下载PDF
导出
摘要 树突状细胞(DCs)在激活天然的免疫反应和获得性免疫反应中具有独一无二的作用,应用DCs为基础的肿瘤免疫治疗已成为肿瘤治疗的研究焦点。改善DCs疫苗的效能的方法有体外DCs策略和体内DCs策略。本文就体外DCs疫苗策略在肿瘤免疫治疗中的研究进展做一综述。 Because of their unique role in linking the innate and adaptive immune systems,dendritic cells（DCs） have been a logical focus for novel immunotherapies.To augment antitumor immunity of DCs,there are two kinds of strategies： ex vivo DCs therapy and in vivo DCs therapy.This review provides a general overview of ex vivo DCs antitumor immunotherapy and summarizes some of the recent advances in this field.
作者 谢军平 叶小群 况九龙
机构地区 南昌大学第二附属医院呼吸内科
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第30期49-52,共4页 China Journal of Modern Medicine
基金 国家自然科学基金项目资助(No:81160294)
关键词 树突状细胞 体外DCs策略 肿瘤免疫治疗 dendritic cells ex vivo DCs therapy tumor immunotherapy
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献30

  • 1KOIDO S, HARA E, HOMMA S, et al. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic ceils and colorectal cancer cells[J]. J Immunol, 2007, 178(1): 613-622.
  • 2KOIDO S, HARA E, HOMMA S, et al. Dendritic/tumor fusion cell-based vaccination against cancer [J]. Arch Immunol Ther Exp, 2007, 55(5): 281-287.
  • 3谢军平(综述),侯晓华,陶晓南(审校).树突状细胞融合瘤苗在肿瘤免疫中的研究进展[J].国际肿瘤学杂志,2008,35(9):664-667. 被引量：1
  • 4FINN OJ. Cancer vaccines: between the idea and the reality[J]. Nat Rev Immunol, 2003, 3(8): 650-641.
  • 5SCHREIBER TH, RAEZ L, ROSENBLATT JD, et al. Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art[J]. Semin Immunol, 2010, 22(3): 105-112.
  • 6INABA K, INABA M, ROMANI N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granuloeyte/maerophage colony-stimulating factor[J]. J Exp Med, 1992, 176(6): 1693-1702.
  • 7JONULEIT H, KUHN U, MULLER G, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions[J]. Eur J Immunol, 1997, 27(12): 3135-3142.
  • 8HARRIS KM. Monocytes differentiated with GM-CSF and IL-15 initiate Th17 and Thl responses that are contact-dependent and mediated by IL-15[J]. J Leukoc Biol, 2011, 90(4): 727-734.
  • 9SANTINI SM, LAPENTA C, LOGOZZI M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice[J]. J Exp Med, 2000, 191(10): 1777-1788.
  • 10ANTONIA S, MULE JJ, WEBER JS. Current developments of immunotherapy in the clinic [J]. Curt Opin Immunol, 2004, 16 (2): 130-136.

二级参考文献22

  • 1Homma S, Kikuchi T, Ishiji N, et al. Cancer immunotherapy by fusion of dendritic and tumor cells and rhIL-12. Eur J Clin Invest, 2005, 35(4) :279-286.
  • 2Koido S, Hara E, Homma S, et al. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells. J Immunnol, 2007, 178( 1 ) :613-622.
  • 3Koido S, Hara E, Torii A, et al. Induction of antigen-specific CD4 and CD8 medialed T cell responses by fusion of autologous dendritic cells and metastatic colorectal cancer cells. Int J Cancer, 2005, 117 (4) :587-595.
  • 4Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol, 2005, 42 (7) :799-809.
  • 5Koido S, Hara E, Homma S, et al. Dendritic/tumor fusion cell- based vaccination against cancer. Arch Immunol Ther Exp, 2007, 55 (5) : 281-287.
  • 6Palucka AK, Dhodapkar MV, Paczesny S, et al. Single injection of CD34 + progenitor-derived dendritic cell vaccine can lead to induction of T- cell immunity in patients with stage Ⅳ melanoma. J Immunother, 2003, 26 (5) :432-439.
  • 7Iinuma T, Homma S, Noda T, et al. Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine. J Clin Invest, 2004, 113, (9) : 1307-1317.
  • 8Koido S, Nikrui N, Ohana M, et al. Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use. Gynecol Oncol, 2005, 99(2) :462-471.
  • 9Mukherjee P, Madsen CS, Ginardi AR, et al. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. J Immunother, 2003, 26( 1 ) :47-62.
  • 10Plunkett T, Graham R, Correa I, et al. Protection against MUC1 expressing mouse tumours by intra-muscular injection of MUC1 cDNA requires functional CD8 + and CD4 + T cells but does not require the MUC1 tandem repeat domain. Int J Cancer, 2004, 109 ( 5 ) : 691- 697.

同被引文献40

  • 1樊建勇,杨慧兰,王颖,关蕾.单纯疱疹病毒2gD-Hsp70融合蛋白基因的构建及表达[J].生物工程学报,2006,22(6):914-918. 被引量：4
  • 2樊建勇,杨慧兰.脂质体包裹HSV-2gD-HSP70融合蛋白诱导小鼠免疫应答的研究[J].中华皮肤科杂志,2007,40(10):609-611. 被引量：1
  • 3Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines[J]. Nat Med, 2004, 10(9) : 909 -915.
  • 4Palucka AK, Ueno H, Fay J, et al. Dendritic cells : a critical player in cancer therapy[ J]. J Immunother, 2008, 3l(9) : 793 - 805.
  • 5Schueneman AJ, Sugar EA, Uram J, et al. Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine [ J ]. Ann Surg Oncol, 2013, 20 ( Suppl 3 ) : $725 - $730.
  • 6Nemunaitis J, Jahan T, Ross H, et al. Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer [ J]. Cancer Gene Ther, 2006, 13 (6) : 555 - 562.
  • 7Le DT, Lutz E, Uram JN, et al. Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer [ J ]. J Immunother, 2013, 36 (7) : 382 -389.
  • 8Ishii K J, Akira S. Toll or Toll-bee adjuvant path toward the optimal vaccine development [ J ]. J Clin Immunol, 2007, 27 ( 4 ) : 363 - 371,.
  • 9Yarovinsky F, Kanzler H, Hieny S, et al. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4^+ T cell response[ J]. Immunity, 2006, 25 (4) : 655 - 664.
  • 10Heit A, Schmitz F, OKeeffe M, et al. Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines[J]. J Immunol, 2005, 174(7) : 4373 -4380.

引证文献2

二级引证文献10

中国现代医学杂志
2012年 第30期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部